Alexander H Flannery
University of Kentucky
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexander H Flannery as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:57 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04558359 · Renin and Renal Biomarker Response to Angiotensin IIAlexander Flannery · completed · Septic Shock, Acute Kidney Injury · principal investigator
- Ph1NCT02716597 · Effect of Albumin Administration on Vasopressor Duration in Resolving Septic ShockAlexander Flannery, 859-323-4011 · terminated · Shock, Septic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation ApproachK23DK128562 · NIDDK · UNIVERSITY OF KENTUCKY · fiscal years 2022 to 2024 · $99,759 awarded in 2024Same name and institution; not confirmed by an ID
- A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury BiomarkersR21AI176298 · NIAID · UNIVERSITY OF KENTUCKY · fiscal years 2023 · $249,623 awarded in 2023Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.